This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rubsam, L. Z. Articles by Shewach, D. S. Search for Related Content PubMed PubMed Citation Articles by Rubsam, L. Z. Articles by Shewach, D. S.

Superior Cytotoxicity with Ganciclovir Compared with Acyclovir and 1-ß-D-Arabinofuranosylthymine in Herpes Simplex Virus-Thymidine Kinase-expressing Cells: A Novel Paradigm for Cell Killing¹

Department of Pharmacology, University of Michigan Medical Center, Ann Arbor, Michigan 48109-0504 [L. Z. R., D. S. S.], and Department of Internal Medicine [B. L. D.], University of Iowa, Iowa City, Iowa 52242

Enzyme-prodrug therapy using ganciclovir and herpes simplex virus-thymidine kinase (HSV-TK) has demonstrated excellent antitumor activity in many different types of malignant cells. Previously, we noted that ganciclovir was substantially more cytotoxic than other HSV-TK substrates. Therefore, we embarked on a study to determine the basis for the superior cytotoxicity of ganciclovir. In U251tk human glioblastoma cells that stably express HSV-TK, ganciclovir elicited a >4 log cell kill instead of the 1.5 log cell kill mediated by two other HSV-TK substrates, 1-ß-D-arabinofuranosylthymine (araT) and acyclovir. Study of the metabolism of these drugs demonstrated that acyclovir was poorly phosphorylated to its active triphosphate with DNA incorporation below the limit of detection, which may explain the <1 log cell kill in these cells. Lower levels of ganciclovir triphosphate accumulated compared with araT triphosphate (araTTP) under conditions that induced 1 log cell kill (67 versus 1235 pmol/10⁷ cells, respectively), and the half-life for the triphosphate of ganciclovir was shorter than that of araT (terminal half-lives of 15 and 41 h, respectively). Incorporation of ganciclovir monophosphate into DNA was less than that of araT monophosphate, and both analogues were retained in DNA for 48 h. Thus, the superior cytotoxicity of ganciclovir was not due to enhanced metabolism to active forms. Highly cytotoxic concentrations of ganciclovir produced only weak inhibition of DNA synthesis. This allowed cells to proceed through S and G₂-M phases during and after drug exposure, resulting in a doubling of cell number by 48 h after drug washout. As they attempted to progress through the cell cycle a second time, ganciclovir-treated cells accumulated in early S-phase and remained there until cell death, suggesting that ganciclovir incorporation in the DNA template was important for cytotoxicity. In contrast, strong inhibition of DNA synthesis by araTTP prevented cells from traversing the cell cycle for at least 12 h after drug washout, when the active metabolite was largely degraded. araT-treated cells were unable to divide for at least 72 h after drug exposure, at which point the surviving cells displayed a normal cell cycle distribution pattern. Based on the results presented here, we propose a novel paradigm in which the ability of ganciclovir to incorporate into DNA without inhibiting progression through S-phase, combined with high cytotoxicity for incorporated ganciclovir monophosphate, produces multilog cytotoxicity.

¹ This work was supported in part by Grants CA46452, CA76581, and Training Grant GM-07767 from the NIH.

² To whom requests for reprints should be addressed, at 4713 Upjohn Center, Department of Pharmacology, University of Michigan Medical Center, 1310 East Catherine, Ann Arbor, MI 48109-0504. Phone: (313) 763-5810; Fax: (313) 763-3438; E-mail: dshewach@umich.edu.

Received 2/ 4/98. Accepted 7/ 1/98.

This article has been cited by other articles:

				B. G. Gentry, P. D. Boucher, and D. S. Shewach Hydroxyurea Induces Bystander Cytotoxicity in Cocultures of Herpes Simplex Virus Thymidine Kinase-Expressing and Nonexpressing HeLa Cells Incubated with Ganciclovir. Cancer Res., April 1, 2006; 66(7): 3845 - 3851. [Abstract] [Full Text] [PDF]

				P. D. Boucher, M. M. Im, S. O. Freytag, and D. S. Shewach A novel mechanism of synergistic cytotoxicity with 5-fluorocytosine and ganciclovir in double suicide gene therapy. Cancer Res., March 15, 2006; 66(6): 3230 - 3237. [Abstract] [Full Text] [PDF]

				M. B. Gill, J.-E. Murphy, and J. D. Fingeroth Functional Divergence of Kaposi's Sarcoma-Associated Herpesvirus and Related Gamma-2 Herpesvirus Thymidine Kinases: Novel Cytoplasmic Phosphoproteins That Alter Cellular Morphology and Disrupt Adhesion J. Virol., December 1, 2005; 79(23): 14647 - 14659. [Abstract] [Full Text] [PDF]

				R. Thust, M.T. Tomicic, R. Grabner, C. Friedrichs, P. Wutzler, and B. Kaina Cytogenetic detection of a trans-species bystander effect: induction of sister chromatid exchanges in murine 3T3 cells by ganciclovir metabolized in HSV thymidine kinase gene-transfected Chinese hamster ovary cells Mutagenesis, January 1, 2004; 19(1): 27 - 33. [Abstract] [Full Text] [PDF]

				T. Suzutani, K. Ishioka, E. De Clercq, K. Ishibashi, H. Kaneko, T. Kira, K.-i. Hashimoto, M. Ogasawara, K. Ohtani, N. Wakamiya, et al. Differential Mutation Patterns in Thymidine Kinase and DNA Polymerase Genes of Herpes Simplex Virus Type 1 Clones Passaged in the Presence of Acyclovir or Penciclovir Antimicrob. Agents Chemother., May 1, 2003; 47(5): 1707 - 1713. [Abstract] [Full Text] [PDF]

				M. Schuldiner, J. Itskovitz-Eldor, and N. Benvenisty Selective Ablation of Human Embryonic Stem Cells Expressing a "Suicide" Gene Stem Cells, May 1, 2003; 21(3): 257 - 265. [Abstract] [Full Text] [PDF]

				M. T. Tomicic, C. Friedrichs, M. Christmann, P. Wutzler, R. Thust, and B. Kaina Apoptosis Induced by (E)-5-(2-Bromovinyl)-2'-deoxyuridine in Varicella Zoster Virus Thymidine Kinase-Expressing Cells Is Driven by Activation of c-Jun/Activator Protein-1 and Fas Ligand/Caspase-8 Mol. Pharmacol., February 1, 2003; 63(2): 439 - 449. [Abstract] [Full Text] [PDF]

				K. E. Mercer, C. E. Ahn, A. Coke, C. M. Compadre, and R. R. Drake Mutation of herpesvirus thymidine kinase to generate ganciclovir-specific kinases for use in cancer gene therapies Protein Eng. Des. Sel., November 1, 2002; 15(11): 903 - 911. [Abstract] [Full Text] [PDF]

				R. Noy, Z. Ben-Zvi, E. Manor, F. Candotti, J. C. Morris, H. Ford Jr, V. E. Marquez, D. G. Johns, and R. Agbaria Antitumor Activity and Metabolic Activation of N-Methanocarbathymidine, a Novel Thymidine Analogue with a Pseudosugar Rigidly Fixed in the Northern Conformation, in Murine Colon Cancer Cells Expressing Herpes Simplex Thymidine Kinase Mol. Cancer Ther., June 1, 2002; 1(8): 585 - 593. [Abstract] [Full Text] [PDF]

				M. T. Tomicic, R. Thust, R. W. Sobol, and B. Kaina DNA Polymerase {beta} Mediates Protection of Mammalian Cells against Ganciclovir-induced Cytotoxicity and DNA Breakage Cancer Res., October 1, 2001; 61(20): 7399 - 7403. [Abstract] [Full Text] [PDF]

				M. Mesnil and H. Yamasaki Bystander Effect in Herpes Simplex Virus-Thymidine Kinase/Ganciclovir Cancer Gene Therapy: Role of Gap-junctional Intercellular Communication1 Cancer Res., August 1, 2000; 60(15): 3989 - 3999. [Abstract] [Full Text]

				R. Thust, M. Tomicic, R. Klocking, P. Wutzler, and B. Kaina Cytogenetic genotoxicity of anti-herpes purine nucleoside analogues in CHO cells expressing the thymidine kinase gene of herpes simplex virus type 1: comparison of ganciclovir, penciclovir and aciclovir Mutagenesis, March 1, 2000; 15(2): 177 - 184. [Abstract] [Full Text] [PDF]

				P. D. Boucher, L. J. Ostruszka, and D. S. Shewach Synergistic Enhancement of Herpes Simplex Virus Thymidine Kinase/Ganciclovir-mediated Cytotoxicity by Hydroxyurea Cancer Res., March 1, 2000; 60(6): 1631 - 1636. [Abstract] [Full Text]

				E. A. Gustafson, R. F. Schinazi, and J. D. Fingeroth Human Herpesvirus 8 Open Reading Frame 21 Is a Thymidine and Thymidylate Kinase of Narrow Substrate Specificity That Efficiently Phosphorylates Zidovudine but Not Ganciclovir J. Virol., January 1, 2000; 74(2): 684 - 692. [Abstract] [Full Text]

				R. R. Drake, T. N. Wilbert, T. A. Hinds, and K. M. Gilbert Differential Ganciclovir-mediated Cell Killing by Glutamine 125 Mutants of Herpes Simplex Virus Type 1 Thymidine Kinase J. Biol. Chem., December 24, 1999; 274(52): 37186 - 37192. [Abstract] [Full Text] [PDF]

				L. Z. Rubsam, P. D. Boucher, P. J. Murphy, M. KuKuruga, and D. S. Shewach Cytotoxicity and Accumulation of Ganciclovir Triphosphate in Bystander Cells Cocultured with Herpes Simplex Virus Type 1 Thymidine Kinase-expressing Human Glioblastoma Cells Cancer Res., February 1, 1999; 59(3): 669 - 675. [Abstract] [Full Text] [PDF]